Findings from the study conducted by Dr Rui’s group support the notion that STAT5A signaling is frequently absent during breast cancer progression and loss of nuclear phospho-Stat5 is associated with poor prognosis in node-negative breast cancer43,44. Here, STAT5A is linked to breast carcinoma.